当前位置:首页 - 行情中心 - 和邦生物(603077) - 财务分析

和邦生物

(603077)

  

流通市值:154.55亿  总市值:154.55亿
流通股本:88.31亿   总股本:88.31亿

和邦生物(603077)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润0.08亿元,每股收益0.00元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益1872535.99万元,未分配利润949017.74万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产2984494.93万元,负债1111958.93万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入1,725,715,319.778,547,476,550.136,813,692,192.924,848,440,513.18
营业总成本1,693,064,580.468,490,183,101.476,550,036,297.84,604,210,077.7
营业利润20,884,096.69-61,792,560.91260,299,739.07245,767,298.4
利润总额20,644,011.1-65,683,562.06259,501,458.7245,320,877.12
净利润7,535,116.9-70,744,609.93195,536,979.04188,048,359.55
其他综合收益14,505,248.27-56,289,225.8-33,076,482.29-16,366,171
综合收益总额22,040,365.17-127,033,835.73162,460,496.75171,682,188.55
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计13,875,476,279.514,003,269,456.6310,828,282,355.3211,135,509,365.2
非流动资产合计15,969,472,970.5515,646,465,083.2515,147,030,324.615,087,400,337.04
资产总计29,844,949,250.0529,649,734,539.8825,975,312,679.9226,222,909,702.24
流动负债合计4,923,063,854.835,374,508,558.615,762,231,159.45,693,927,932.45
非流动负债合计6,196,525,475.195,268,707,775.63832,292,622.49911,417,584.52
负债合计11,119,589,330.0210,643,216,334.246,594,523,781.896,605,345,516.97
归属于母公司股东权益合计18,468,988,158.6518,626,392,431.8718,764,699,737.5118,978,485,274.56
股东权益合计18,725,359,920.0319,006,518,205.6419,380,788,898.0319,617,564,185.27
负债和股东权益合计29,844,949,250.0529,649,734,539.8825,975,312,679.9226,222,909,702.24
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计1,663,561,006.737,679,632,279.65,330,288,586.73,466,445,308.19
经营活动现金流出小计1,718,152,415.437,211,700,892.435,467,511,402.223,569,929,423.41
经营活动产生的现金流量净额-54,591,408.7467,931,387.17-137,222,815.52-103,484,115.22
投资活动现金流入小计30,851,147.3845,571,519.0324,155,473.9110,441,856.14
投资活动现金流出小计368,932,073.751,432,690,999.8788,665,017.11511,395,927.88
投资活动产生的现金流量净额-338,080,926.37-1,387,119,480.77-764,509,543.2-500,954,071.74
筹资活动现金流入小计2,279,208,350.858,140,310,049.052,869,202,966.792,494,399,219.58
筹资活动现金流出小计1,674,186,984.183,293,099,772.232,501,497,326.91,944,509,347.4
筹资活动产生的现金流量净额605,021,366.674,847,210,276.82367,705,639.89549,889,872.18
汇率变动对现金及现金等价物的影响1,784,946.918,709,035.49-4,277,0814,612,832.96
现金及现金等价物净增加额214,133,978.53,946,731,218.71-538,303,799.83-49,935,481.82
期末现金及现金等价物余额7,065,697,039.296,851,563,060.792,366,528,042.252,854,896,360.26
TOP↑